Synthetic peptide conjugated to KLH, corresponding to a region within N terminal amino acids 138-168 of Human FGFRL1 (NP_001004358.1, NP_068742.2, NP_001004356.1).
Shipped at 4°C. Store at 4°C (up to 6 months). Store at -20°C long term.
Preservative: 0.09% Sodium azide
Constituent: 99% PBS
Concentration information loading...
Immunogen affinity purified
ab112917 is purified through a protein A column, followed by peptide affinity purification.
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/100 - 1/500. Predicted molecular weight: 55 kDa.
Has a negative effect on cell proliferation.
Expressed preferentially in cartilaginous tissues and pancreas. Highly expressed in the liver, kidney, heart, brain and skeletal muscle. Weakly expressed in the lung, small intestine and spleen.
Contains 3 Ig-like C2-type (immunoglobulin-like) domains.
Membrane. Predominantly localized in the plasma membrane but also detected in the Golgi and in secretory vesicles.
Information by UniProt
- FGF homologous factor receptor antibody
- FGF receptor like protein 1 antibody
- FGF receptor-like protein 1 antibody
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"